Investor capital plays a pivotal role in fueling startups at the forefront of reshaping health care. Over the past decade, record levels of financial investment within health care at the industry level have helped bring innovation as well as public attention to the potential for growth in the space. By supporting new ventures, investors not only foster groundbreaking solutions but also promote resilience and adaptability in the face of unprecedented challenges. The COVID-19 Pandemic served as both an accelerant and road-block to many promising developments, as we've seen dynamic changes to how, where, and through what channels health care is delivered. Our panel explores how strategic investments can drive positive transformations, reduce inequalities, and contribute to a more resilient, patient-centric health care ecosystem, where adversity becomes an opportunity for innovation and progress.

Payers are uniquely positioned to leverage data and analytics to address the mounting challenges of enhancing patient outcomes and mitigating growing health care costs. Executing this strategy requires stronger partnerships with providers and data aggregators while in parallel safeguarding patient privacy and improving equity. During our panel discussion, we will delve into several promising innovations in the space and evaluate their scalability and sustainability.

Within the ever-changing medical landscape, therapeutic development and refinement remain paramount to success. Recent innovations in Artificial Intelligence and big data technologies provide the perfect vehicle to inspire this change for both the present and future. Our discussion will explore the pivotal role of AI in fast-tracking drug discovery and clinical trials, identifying secondary and novel therapeutic options for patients who have experienced treatment failures, and fortifying resilience in the post-launch landscape. Join us as we explore the multifaceted applications of AI in therapeutic innovation.

Health care is not limited to the four walls of a doctor’s office. Social Determinants of Health (SDoH) significantly drive our health outcomes and risks. The COVID-19 pandemic highlighted this and we saw that social factors like income, education, and occupation influenced what populations were hit first and hit hardest. Health care shocks are systemic, but their incidence is not distributed evenly across the system and their treatment is not possible without addressing underlying SDoH causes. This panel will explore how effective care delivery and recovery is better served across the health care ecosystem by addressing SDoH.

Aging population demographics have been putting increasing pressure on health care systems. As a result, care has been increasingly shifting from physical facilities to the home. Across different accuity levels, patients are increasingly expecting to age gracefully at home and new technologies and service models have facilitated this transition. This panel will explore the evolving at-home care landscape and what innovative payment, technology, and service models are driving a new standard for elder care.

We are just beginning to unlock the potential for innovation in women’s health care, an industry that faces adversity from social stigma, barriers to access, rising costs, and historical funding biases. Women’s health care needs evolve at different stages of life, from adolescence to pregnancy, menopause, and beyond, and these solutions are often disconnected. Emerging players across the women’s health ecosystem are beginning to tackle these issues, transforming care and ultimately empowering women to better identify and navigate these resources. In this panel, we will engage with prominent thought leaders in the field to explore the multifaceted challenges women face throughout their lives and the innovative solutions that are transforming the landscape of women’s health care.